Shopping Cart 0
Cart Subtotal
AED 0

Pharmaceuticals in Singapore

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 1285

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 2569

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 3854
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Pharmaceuticals in Singapore

 

Summary

 

Pharmaceuticals in Singapore industry profile provides top-line qualitative and quantitative summary information including: market size (value 2014-18, and forecast to 2023). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

 

Key Highlights

 

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.

- The Singaporean pharmaceuticals market had total revenues of USD 1.0m in 2018, representing a compound annual growth rate (CAGR) of 4.9% between 2014 and 2018.

- The performance of the market is forecast to follow a similar pattern with an anticipated CAGR of 4.8% for the five-year period 2018-2023, which is expected to drive the market to a value of USD 1.3m by the end of 2023.

- Singapore remains unique relative to other markets in punching above its weight in terms of size and population.

 

Scope

 

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Singapore

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Singapore

- Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the Singapore pharmaceuticals market with five year forecasts

 

Reasons to buy

 

- What was the size of the Singapore pharmaceuticals market by value in 2018?

- What will be the size of the Singapore pharmaceuticals market in 2023?

- What factors are affecting the strength of competition in the Singapore pharmaceuticals market?

- How has the market performed over the last five years?

- How large is Singapore's pharmaceuticals market in relation to its regional counterparts?

READ MORE

Table Of Content

Scope

Table of Contents

Executive Summary

Market value

Market value forecast

Geography segmentation

Market share

Market rivalry

Market Overview

Market definition

Market analysis

Market Data

Market value

Market Segmentation

Geography segmentation

Market share

Market Outlook

Market value forecast

Five Forces Analysis

Summary

Buyer power

Supplier power

New entrants

Threat of substitutes

Degree of rivalry

Leading Companies

Aspen Pharmacare Holdings Ltd

GlaxoSmithKline Plc

Novartis AG

Pfizer Inc

Macroeconomic Indicators

Country data

Methodology

Industry associations

Related MarketLine research

Appendix

About MarketLine


List Of Figure

List of Figures

Figure 1: Singapore pharmaceuticals market value: USD billion, 2014-18

Figure 2: Singapore pharmaceuticals market geography segmentation: % share, by value, 2018

Figure 3: Singapore pharmaceuticals market share: % share, by value, 2018

Figure 4: Singapore pharmaceuticals market value forecast: USD billion, 2018-23

Figure 5: Forces driving competition in the pharmaceuticals market in Singapore, 2018

Figure 6: Drivers of buyer power in the pharmaceuticals market in Singapore, 2018

Figure 7: Drivers of supplier power in the pharmaceuticals market in Singapore, 2018

Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Singapore, 2018

Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Singapore, 2018

Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Singapore, 2018

Figure 11: Aspen Pharmacare Holdings Ltd: revenues & profitability

Figure 12: Aspen Pharmacare Holdings Ltd: assets & liabilities

Figure 13: GlaxoSmithKline Plc: revenues & profitability

Figure 14: GlaxoSmithKline Plc: assets & liabilities

Figure 15: Novartis AG: revenues & profitability

Figure 16: Novartis AG: assets & liabilities

Figure 17: Pfizer Inc: revenues & profitability

Figure 18: Pfizer Inc: assets & liabilities


List Of Table

List of Tables

Table 1: Singapore pharmaceuticals market value: USD billion, 2014-18

Table 2: Singapore pharmaceuticals market geography segmentation: USD billion, 2018

Table 3: Singapore pharmaceuticals market share: % share, by value, 2018

Table 4: Singapore pharmaceuticals market value forecast: USD billion, 2018-23

Table 5: Aspen Pharmacare Holdings Ltd: key facts

Table 6: Aspen Pharmacare Holdings Ltd: key financials (USD )

Table 7: Aspen Pharmacare Holdings Ltd: key financials (ZAR)

Table 8: Aspen Pharmacare Holdings Ltd: key financial ratios

Table 9: GlaxoSmithKline Plc: key facts

Table 10: GlaxoSmithKline Plc: key financials (USD )

Table 11: GlaxoSmithKline Plc: key financials (GBP)

Table 12: GlaxoSmithKline Plc: key financial ratios

Table 13: Novartis AG: key facts

Table 14: Novartis AG: key financials (USD )

Table 15: Novartis AG: key financial ratios

Table 16: Pfizer Inc: key facts

Table 17: Pfizer Inc: key financials (USD )

Table 18: Pfizer Inc: key financial ratios

Table 19: Singapore size of population (million), 2014-18

Table 20: Singapore gdp (constant 2005 prices, USD billion), 2014-18

Table 21: Singapore gdp (current prices, USD billion), 2014-18

Table 22: Singapore inflation, 2014-18

Table 23: Singapore consumer price index (absolute), 2014-18

Table 24: Singapore exchange rate, 2014-18

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

Aspen Pharmacare Holdings Ltd

GlaxoSmithKline Plc

Novartis AG

Pfizer Inc

Pharmaceuticals in Singapore

 

Summary

 

Pharmaceuticals in Singapore industry profile provides top-line qualitative and quantitative summary information including: market size (value 2014-18, and forecast to 2023). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

 

Key Highlights

 

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.

- The Singaporean pharmaceuticals market had total revenues of USD 1.0m in 2018, representing a compound annual growth rate (CAGR) of 4.9% between 2014 and 2018.

- The performance of the market is forecast to follow a similar pattern with an anticipated CAGR of 4.8% for the five-year period 2018-2023, which is expected to drive the market to a value of USD 1.3m by the end of 2023.

- Singapore remains unique relative to other markets in punching above its weight in terms of size and population.

 

Scope

 

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Singapore

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Singapore

- Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the Singapore pharmaceuticals market with five year forecasts

 

Reasons to buy

 

- What was the size of the Singapore pharmaceuticals market by value in 2018?

- What will be the size of the Singapore pharmaceuticals market in 2023?

- What factors are affecting the strength of competition in the Singapore pharmaceuticals market?

- How has the market performed over the last five years?

- How large is Singapore's pharmaceuticals market in relation to its regional counterparts?

READ MORE

Scope

Table of Contents

Executive Summary

Market value

Market value forecast

Geography segmentation

Market share

Market rivalry

Market Overview

Market definition

Market analysis

Market Data

Market value

Market Segmentation

Geography segmentation

Market share

Market Outlook

Market value forecast

Five Forces Analysis

Summary

Buyer power

Supplier power

New entrants

Threat of substitutes

Degree of rivalry

Leading Companies

Aspen Pharmacare Holdings Ltd

GlaxoSmithKline Plc

Novartis AG

Pfizer Inc

Macroeconomic Indicators

Country data

Methodology

Industry associations

Related MarketLine research

Appendix

About MarketLine


List Of Figure

List of Figures

Figure 1: Singapore pharmaceuticals market value: USD billion, 2014-18

Figure 2: Singapore pharmaceuticals market geography segmentation: % share, by value, 2018

Figure 3: Singapore pharmaceuticals market share: % share, by value, 2018

Figure 4: Singapore pharmaceuticals market value forecast: USD billion, 2018-23

Figure 5: Forces driving competition in the pharmaceuticals market in Singapore, 2018

Figure 6: Drivers of buyer power in the pharmaceuticals market in Singapore, 2018

Figure 7: Drivers of supplier power in the pharmaceuticals market in Singapore, 2018

Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Singapore, 2018

Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Singapore, 2018

Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Singapore, 2018

Figure 11: Aspen Pharmacare Holdings Ltd: revenues & profitability

Figure 12: Aspen Pharmacare Holdings Ltd: assets & liabilities

Figure 13: GlaxoSmithKline Plc: revenues & profitability

Figure 14: GlaxoSmithKline Plc: assets & liabilities

Figure 15: Novartis AG: revenues & profitability

Figure 16: Novartis AG: assets & liabilities

Figure 17: Pfizer Inc: revenues & profitability

Figure 18: Pfizer Inc: assets & liabilities


List Of Table

List of Tables

Table 1: Singapore pharmaceuticals market value: USD billion, 2014-18

Table 2: Singapore pharmaceuticals market geography segmentation: USD billion, 2018

Table 3: Singapore pharmaceuticals market share: % share, by value, 2018

Table 4: Singapore pharmaceuticals market value forecast: USD billion, 2018-23

Table 5: Aspen Pharmacare Holdings Ltd: key facts

Table 6: Aspen Pharmacare Holdings Ltd: key financials (USD )

Table 7: Aspen Pharmacare Holdings Ltd: key financials (ZAR)

Table 8: Aspen Pharmacare Holdings Ltd: key financial ratios

Table 9: GlaxoSmithKline Plc: key facts

Table 10: GlaxoSmithKline Plc: key financials (USD )

Table 11: GlaxoSmithKline Plc: key financials (GBP)

Table 12: GlaxoSmithKline Plc: key financial ratios

Table 13: Novartis AG: key facts

Table 14: Novartis AG: key financials (USD )

Table 15: Novartis AG: key financial ratios

Table 16: Pfizer Inc: key facts

Table 17: Pfizer Inc: key financials (USD )

Table 18: Pfizer Inc: key financial ratios

Table 19: Singapore size of population (million), 2014-18

Table 20: Singapore gdp (constant 2005 prices, USD billion), 2014-18

Table 21: Singapore gdp (current prices, USD billion), 2014-18

Table 22: Singapore inflation, 2014-18

Table 23: Singapore consumer price index (absolute), 2014-18

Table 24: Singapore exchange rate, 2014-18

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Companies

Aspen Pharmacare Holdings Ltd

GlaxoSmithKline Plc

Novartis AG

Pfizer Inc